These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25066760)

  • 141. Aberrant alteration of peripheral B lymphocyte subsets in hepatocellular carcinoma patients.
    Wu J; Wang Y; Bai S; Sun H; Zhang J; Shu J; Wang Y; Tan M; Zhou L; Huang B; Pan Q; Sheng H
    Int J Med Sci; 2023; 20(2):267-277. PubMed ID: 36794164
    [TBL] [Abstract][Full Text] [Related]  

  • 142. Tumor-specific hepatic stellate cells (tHSCs) induces DIgR2 expression in dendritic cells to inhibit T cells.
    Xia YH; Lu Z; Zhao M; Dai WT; Ding L; Hu LX; Jiang GL
    Oncotarget; 2017 Aug; 8(33):55084-55093. PubMed ID: 28903404
    [TBL] [Abstract][Full Text] [Related]  

  • 143. Elucidation of the Differences in Cinobufotalin's Pharmacokinetics Between Normal and Diethylnitrosamine-Injured Rats: The Role of P-Glycoprotein.
    Zhang X; Liu T; Zhang Y; Liu F; Li H; Fang D; Wang C; Sun H; Xie S
    Front Pharmacol; 2019; 10():521. PubMed ID: 31156437
    [TBL] [Abstract][Full Text] [Related]  

  • 144. Chemically-induced cancers do not originate from bone marrow-derived cells.
    Lin H; Hu L; Chen L; Yu H; Wang Q; Chen P; Hu XT; Cai XJ; Guan XY
    PLoS One; 2012; 7(1):e30493. PubMed ID: 22291966
    [TBL] [Abstract][Full Text] [Related]  

  • 145. DEN-Induced Rat Model Reproduces Key Features of Human Hepatocellular Carcinoma.
    Kurma K; Manches O; Chuffart F; Sturm N; Gharzeddine K; Zhang J; Mercey-Ressejac M; Rousseaux S; Millet A; Lerat H; Marche PN; Macek Jilkova Z; Decaens T
    Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638465
    [TBL] [Abstract][Full Text] [Related]  

  • 146. Evaluation of Luteolin in the Prevention of N-nitrosodiethylamine-induced Hepatocellular Carcinoma Using Animal Model System.
    Balamurugan K; Karthikeyan J
    Indian J Clin Biochem; 2012 Apr; 27(2):157-63. PubMed ID: 23543260
    [TBL] [Abstract][Full Text] [Related]  

  • 147. Message in a bottle from the tumor microenvironment: tumor-educated DCs instruct B cells to participate in immunosuppression.
    Mion F; Tonon S; Valeri V; Pucillo CE
    Cell Mol Immunol; 2017 Sep; 14(9):730-732. PubMed ID: 28757609
    [No Abstract]   [Full Text] [Related]  

  • 148. Bioenergetic Phenotyping of DEN-Induced Hepatocellular Carcinoma Reveals a Link Between Adenylate Kinase Isoform Expression and Reduced Complex I-Supported Respiration.
    McLaughlin KL; Nelson MAM; Coalson HS; Hagen JT; Montgomery MM; Wooten AR; Zeczycki TN; Vohra NA; Fisher-Wellman KH
    Front Oncol; 2022; 12():919880. PubMed ID: 35756609
    [TBL] [Abstract][Full Text] [Related]  

  • 149. Statins, Tregs and cancer.
    Goldstein MR; Mascitelli L; Pezzetta F
    Atherosclerosis; 2008 Jan; 196(1):483-484. PubMed ID: 17977547
    [No Abstract]   [Full Text] [Related]  

  • 150. Different but synergistic effects of bone marrow-derived VEGFR2
    Zhu X; Zhou H; Luo J; Cui Y; Li H; Zhang W; Fang F; Li Q; Zhang T
    Oncol Lett; 2017 Jan; 13(1):63-68. PubMed ID: 28123523
    [TBL] [Abstract][Full Text] [Related]  

  • 151. TLS in Tumors: What Lies Within.
    Sautès-Fridman C; Fridman WH
    Trends Immunol; 2016 Jan; 37(1):1-2. PubMed ID: 26706045
    [TBL] [Abstract][Full Text] [Related]  

  • 152. Rheumatoid arthritis: Defective IL-10-producing B
    Ummarino D
    Nat Rev Rheumatol; 2017 Mar; 13(3):132. PubMed ID: 28148914
    [No Abstract]   [Full Text] [Related]  

  • 153. The DEN and CCl4 -Induced Mouse Model of Fibrosis and Inflammation-Associated Hepatocellular Carcinoma.
    Uehara T; Pogribny IP; Rusyn I
    Curr Protoc Pharmacol; 2014 Sep; 66():14.30.1-14.30.10. PubMed ID: 25181010
    [TBL] [Abstract][Full Text] [Related]  

  • 154. PD-1hi Identifies a Novel Regulatory B-cell Population in Human Hepatoma That Promotes Disease Progression.
    Xiao X; Lao XM; Chen MM; Liu RX; Wei Y; Ouyang FZ; Chen DP; Zhao XY; Zhao Q; Li XF; Liu CL; Zheng L; Kuang DM
    Cancer Discov; 2016 May; 6(5):546-59. PubMed ID: 26928313
    [TBL] [Abstract][Full Text] [Related]  

  • 155. Diethylnitrosamine Induction of Hepatocarcinogenesis in Mice.
    Sotty J; Bablon P; Weiss PH; Soussan P
    Methods Mol Biol; 2024; 2769():15-25. PubMed ID: 38315386
    [TBL] [Abstract][Full Text] [Related]  

  • 156. Tumor Microenvironment Composition and Related Therapy in Hepatocellular Carcinoma.
    Li Z; Zhang Z; Fang L; Zhao J; Niu Z; Chen H; Cao G
    J Hepatocell Carcinoma; 2023; 10():2083-2099. PubMed ID: 38022729
    [TBL] [Abstract][Full Text] [Related]  

  • 157. Cellular based immunotherapy for primary liver cancer.
    Zheng Y; Li Y; Feng J; Li J; Ji J; Wu L; Yu Q; Dai W; Wu J; Zhou Y; Guo C
    J Exp Clin Cancer Res; 2021 Aug; 40(1):250. PubMed ID: 34372912
    [TBL] [Abstract][Full Text] [Related]  

  • 158. Current Perspectives on B Lymphocytes in the Immunobiology of Hepatocellular Carcinoma.
    Qin M; Wang D; Fang Y; Zheng Z; Liu X; Wu F; Wang L; Li X; Hui B; Ma S; Tang W; Pan X
    Front Oncol; 2021; 11():647854. PubMed ID: 34235074
    [TBL] [Abstract][Full Text] [Related]  

  • 159. The Role of Regulatory B Cells in Patients with Acute Myeloid Leukemia.
    Lv Y; Wang H; Liu Z
    Med Sci Monit; 2019 Apr; 25():3026-3031. PubMed ID: 31017878
    [TBL] [Abstract][Full Text] [Related]  

  • 160. Down-regulation of siglec-2 (CD22) predicts worse overall survival from HBV-related early-stage hepatocellular carcinoma: a preliminary analysis from Gene Expression Omnibus.
    Ren X; Ji Y; Jiang X; Qi X
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30355653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.